These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intestinal absorption characteristics of buformin and phenformin in rats. Kojima S; Tanaka R; Hamada C Chem Pharm Bull (Tokyo); 1976 Jul; 24(7):1555-60. PubMed ID: 975421 [No Abstract] [Full Text] [Related]
4. The fate of biguanides in man. Beckmann R Ann N Y Acad Sci; 1968 Mar; 148(3):820-32. PubMed ID: 5241479 [No Abstract] [Full Text] [Related]
5. Metabolism, plasma or serum levels, and elimination of phenformin in guinea pigs, rats, and dogs. Alkalay D; Volk J; Roth W; Khemani L; Bartlett MF J Pharm Sci; 1979 Feb; 68(2):156-60. PubMed ID: 423081 [TBL] [Abstract][Full Text] [Related]
6. [Absorption, distribution in the organism and elimination of metformin]. Beckmann R Diabetologia; 1969 Oct; 5(5):318-24. PubMed ID: 5360810 [No Abstract] [Full Text] [Related]
7. [Animal experimental studies on the mode of action of biguanides. 1. Studies on non hypoglycemically acting biguanide]. Losert W; Schillinger E; Kraaz W; Loge O; Jahn P Arzneimittelforschung; 1972 Sep; 22(9):1540-52. PubMed ID: 4678618 [No Abstract] [Full Text] [Related]
8. Liver uptake of biguanides in rats. Sogame Y; Kitamura A; Yabuki M; Komuro S Biomed Pharmacother; 2011 Sep; 65(6):451-5. PubMed ID: 21880461 [TBL] [Abstract][Full Text] [Related]
9. [Availability of phenformin in an oral sustained-release form]. Bramanti G Boll Chim Farm; 1973 Jul; 112(7):472-8. PubMed ID: 4765108 [No Abstract] [Full Text] [Related]
10. Characterization of phenformin and metabolites in plasma. Heuclin C; Pene F; Savouret JF; Assan R Diabete Metab; 1975 Dec; 1(4):234-40. PubMed ID: 1234583 [TBL] [Abstract][Full Text] [Related]
11. Toxic nephrosis in rabbits caused by the hypoglycemic biguanide, phenformin. LAZARUS SS; BRADSHAW M; VOLK BW Diabetes; 1960; 9():118-25. PubMed ID: 14414807 [No Abstract] [Full Text] [Related]
12. Antidiabetic behavior of biguanides. Vicente-Pedrós F; Trejueque Monge J; Tomás Vert F J Pharm Sci; 1983 May; 72(5):565-7. PubMed ID: 6345751 [TBL] [Abstract][Full Text] [Related]
13. [Chemistry, toxicology, pharmacodynamics and mechanism of action of biguanides]. Ezechieli S Clin Ter; 1970 Aug; 54(4):351-80. PubMed ID: 4992475 [No Abstract] [Full Text] [Related]
14. Tissue distribution and excretion of phenformin in normal and diabetic animals. Hall H; Ramachander G; Glassman JM Ann N Y Acad Sci; 1968 Mar; 148(3):601-11. PubMed ID: 4385357 [No Abstract] [Full Text] [Related]
15. [Biguanide--its mechanism of action and indication]. Tarui S; Kono N Nihon Rinsho; 1969 Aug; 27(8):2004-11. PubMed ID: 4243054 [No Abstract] [Full Text] [Related]
16. [Distribution of 1-butyl-biguanide- 14 C in rats and guinea pigs]. Losert W; Kolb KH; Bitterling G Arzneimittelforschung; 1972 May; 22(5):937-46. PubMed ID: 5068215 [No Abstract] [Full Text] [Related]
18. [CHANGES IN THE POTENCY OF CHLORPROMAZINE AND HYPOGLYCEMIC BIGUANIDES BY COMBINED ADMINISTRATION]. WIEZOREK WD; GRAUPNER K; CIEPLIK U Med Exp Int J Exp Med; 1963; 8():237-41. PubMed ID: 14044346 [No Abstract] [Full Text] [Related]
19. [Impairment of intestinal glucose absorption by biguanide derivatives]. Czyzyk A Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():636-43. PubMed ID: 5371309 [No Abstract] [Full Text] [Related]
20. Studies on steroid conjugates. XI. Biosynthesis of 16-epiestriol glucosiduronate. Nambara T; Matsuki Y; Kurata M Chem Pharm Bull (Tokyo); 1972 Dec; 20(12):2607-12. PubMed ID: 4652822 [No Abstract] [Full Text] [Related] [Next] [New Search]